Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The increased risk of cardiovascular morbidity and mortality associated with arterial hypertension is particularly pronounced in patients with type 2 diabetes mellitus. Blood pressure control is, therefore, decisively important but often not sufficiently achieved.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Hypertens.

Title: Journal of hypertension

ISSN (Electronic): 1473-5598

ISSN (Print): 0263-6352

Publication date (Electronic): Oct 2013

Volume: 31

Issue: 10

Affiliations

[1 ] aDepartment of Endocrinology, Odense University Hospital, Odense bSteno Diabetes Centre, Gentofte cDepartment of Medicine, Sygehus Lillebælt, Fredericia dDepartment of Endocrinology, Sydvestjysk Sygehus, Esbjerg, Denmark.

Article

Publisher Item ID: 00004872-201310000-00025

DOI: 10.1097/HJH.0b013e3283638b1a

PubMed ID: 24107738

SO-VID: d8ecf831-d910-4c0f-8b8f-33643ca00a45

History

Data availability:

Comments

Comment on this article

scite_

Cited by 40

See all cited by